Pradeyrol Développement
Paris family office founded in 2007 by Dr Christian Pradeyrol; holds stakes in about a dozen biotech companies in France and the US (vaccines, drugs, diagnostics).
USEFUL FOR Co-investors
Family & background
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2007
Investment approach
- SECTORS
- HealthTech
- GEOGRAPHY
- FranceUnited States
- ROUTES
- Direct investments
Overview
Pradeyrol Développement is a Paris company (SIREN 499 588 994, LEI 549300JQZDVP47IG2C98) created in 2007. Its founder and executive chairman, Dr Christian Pradeyrol, is a former anaesthesiologist who founded the CHP private clinics group, acquired by Blackstone in 2007. Osivax describes Pradeyrol Développement as a family office investing in new technologies, with stakes in about a dozen biotech companies in France and the US, focused on immunology, preventive medicine, vaccines, drugs and diagnostics.
Investment thesis
Interested in immunology and preventive medicine: vaccines, drugs and diagnostics, through stakes in biotech companies in France and the US.
Holdings & investments (1)
- OsivaxHealthTech
People
- Dr Christian PradeyrolFounder and Executive Chairman · source
Classification
Single Family Office. Manages one family's own capital, with no outside investors. The family bears every loss. How family capital is classified →
FAQ
Pradeyrol Développement is a single family office based in Paris, France, founded in 2007.
Pradeyrol Développement invests directly in companies.
Pradeyrol Développement invests in HealthTech.
Key people at Pradeyrol Développement include Dr Christian Pradeyrol (Founder and Executive Chairman).
Pradeyrol Développement's holdings and investments include Osivax.